Swiss stocks - Factors to watch on September 21

Basilea Pharmaceutica AG, Allschwil

21/09/2022 05:34

ZURICH/BERLIN, Sept 21(Reuters) - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
    
    NOVARTIS  NOVN.S  
    Novartis plans to ask the U.S. Supreme court to uphold the
validity of a patent it holds on the dosing regimen for multiple
sclerosis drug Gilenya after suffering a setback in a federal
appeals court ruling, the Swiss drugmaker said  NOVN.S 
    
    JULIUS BAER  BAER.S 
    The wealth manager Julius Baer said it was making a
low-double-digit-million U.S. dollar equity investment in GROW,
a China-based domestic asset management company, taking its
first step into the onshore China market  BAER.S 
      
    COMPANY STATEMENTS
    * Novartis  NOVN.S  and Pan-Canadian Pharmaceutical Alliance
(PCPA) conclude negotiations for Luxturna 
    * Basilea  BSLN.S  announces closing of CHF 75 million
senior secured loan agreement with Athyrium  BSLN.S 
        
    EX-DIVIDEND
    RICHEMONT  CFR.S  - 2.25 CHF/shr dividend
    
    ECONOMY
    Swiss August M3 due at 0700 GMT

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))